Hydroxychloroquine and Gefitinib to Treat Lung Cancer

Clinical trial NCT00809237 · UNKNOWN

Trial details

NCT number: NCT00809237
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2008-11-01
Primary completion: 2014-11-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.